GB1219606A
(en)
|
1968-07-15 |
1971-01-20 |
Rech S Et D Applic Scient Soge |
Quinuclidinol derivatives and preparation thereof
|
IT1016489B
(it)
|
1974-03-18 |
1977-05-30 |
Isf Spa |
Inalatore
|
GB8923590D0
(en)
|
1989-10-19 |
1989-12-06 |
Pfizer Ltd |
Antimuscarinic bronchodilators
|
PT100441A
(pt)
|
1991-05-02 |
1993-09-30 |
Smithkline Beecham Corp |
Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
|
JPH0525045A
(ja)
|
1991-07-18 |
1993-02-02 |
Tanabe Seiyaku Co Ltd |
経皮吸収製剤
|
WO1993018007A1
(en)
|
1992-03-13 |
1993-09-16 |
Tokyo Tanabe Company Limited |
Novel carbostyril derivative
|
WO1993019750A1
(en)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic or inflammatory diseases
|
US5605923A
(en)
|
1992-04-02 |
1997-02-25 |
Smithkline Beecham Corporation |
Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
|
MX9301943A
(es)
|
1992-04-02 |
1994-08-31 |
Smithkline Beecham Corp |
Compuestos.
|
US6596260B1
(en)
|
1993-08-27 |
2003-07-22 |
Novartis Corporation |
Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
|
DK0865302T3
(da)
|
1995-12-07 |
2000-10-02 |
Jago Pharma Ag |
Inhalator til gentagen dosisvis afgivelse af farmakologisk tørpulver
|
JP3830972B2
(ja)
|
1996-02-21 |
2006-10-11 |
シェーリング コーポレイション |
粉体薬剤吸入器
|
GB9622386D0
(en)
|
1996-10-28 |
1997-01-08 |
Sandoz Ltd |
Organic compounds
|
US6166037A
(en)
|
1997-08-28 |
2000-12-26 |
Merck & Co., Inc. |
Pyrrolidine and piperidine modulators of chemokine receptor activity
|
AU9281298A
(en)
|
1997-10-01 |
1999-04-23 |
Kyowa Hakko Kogyo Co. Ltd. |
Benzodioxole derivatives
|
US6541669B1
(en)
|
1998-06-08 |
2003-04-01 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
BR9815931A
(pt)
|
1998-06-30 |
2001-02-20 |
Dow Chemical Co |
Polióis poliméricos, um processo para sua produção, e espuma de poliuretanoobtida
|
DE19834047A1
(de)
|
1998-07-29 |
2000-02-03 |
Bayer Ag |
Substituierte Pyrazolderivate
|
DE19834044A1
(de)
|
1998-07-29 |
2000-02-03 |
Bayer Ag |
Neue substituierte Pyrazolderivate
|
GB9913083D0
(en)
|
1999-06-04 |
1999-08-04 |
Novartis Ag |
Organic compounds
|
PL203116B1
(pl)
|
1999-05-04 |
2009-08-31 |
Schering Corp |
Piperazynopiperydynowa pochodna użyteczna jako antagonista CCR5, zawierająca ją kompozycja farmaceutyczna i jej zastosowanie
|
NZ514675A
(en)
|
1999-05-04 |
2004-05-28 |
Schering Corp |
Piperidine derivatives useful as CCR5 antagonists
|
US6683115B2
(en)
|
1999-06-02 |
2004-01-27 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
SK287231B6
(sk)
|
1999-08-21 |
2010-04-07 |
Nycomed Gmbh |
Liečivo zahŕňajúce PDE inhibítor a agonistu beta2 adrenoreceptora
|
DE19943636A1
(de)
|
1999-09-13 |
2001-03-15 |
Bayer Ag |
Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
DE19943639A1
(de)
|
1999-09-13 |
2001-03-15 |
Bayer Ag |
Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften
|
DE19943634A1
(de)
|
1999-09-13 |
2001-04-12 |
Bayer Ag |
Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
DE19943635A1
(de)
|
1999-09-13 |
2001-03-15 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
KR20020093083A
(ko)
|
2000-04-27 |
2002-12-12 |
베링거 잉겔하임 파르마 카게 |
신규한 완효성 베타모사체, 이의 제조방법 및 약제로서의이의 용도
|
ES2213703T5
(es)
|
2000-06-27 |
2011-11-02 |
Laboratorios S.A.L.V.A.T., S.A. |
Carbamatos derivados de arilalquilaminas.
|
GB0015876D0
(en)
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
AR032361A1
(es)
|
2000-08-05 |
2003-11-05 |
Glaxo Group Ltd |
Derivados de androstano y sales y solvatos de los mismos, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que comprenden tales compuestos, proceso para la preparacion de dichos compuestos, e intermediarios utiles en la preparacion de tales compuestos
|
KR20080014934A
(ko)
|
2000-11-07 |
2008-02-14 |
노파르티스 아게 |
단백질 키나제 c 억제제로서의 인돌릴말레이미드 유도체
|
GB0028383D0
(en)
|
2000-11-21 |
2001-01-03 |
Novartis Ag |
Organic compounds
|
AR031176A1
(es)
|
2000-11-22 |
2003-09-10 |
Bayer Ag |
Nuevos derivados de pirazolpiridina sustituidos con piridina
|
WO2002051841A1
(en)
|
2000-12-22 |
2002-07-04 |
Almirall Prodesfarma Ag |
Quinuclidine carbamate derivatives and their use as m3 antagonists
|
AU2002238471B2
(en)
|
2000-12-28 |
2007-06-28 |
Almirall, S.A. |
Quinuclidine derivatives and their use as M3 antagonists
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
DE10110749A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Substituierte Aminodicarbonsäurederivate
|
DE10110750A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
DE60220887T2
(de)
|
2001-03-08 |
2008-02-28 |
Glaxo Group Ltd., Greenford |
Agonisten von beta-adrenorezeptoren
|
US7045658B2
(en)
|
2001-03-22 |
2006-05-16 |
Glaxo Group Limited |
Formailide derivatives as beta2-adrenoreceptor agonists
|
WO2002088167A1
(en)
|
2001-04-30 |
2002-11-07 |
Glaxo Group Limited |
Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
|
JP2005500290A
(ja)
|
2001-06-12 |
2005-01-06 |
グラクソ グループ リミテッド |
抗炎症性の、17β−カルボチオアートアンドロスタン誘導体である17α複素環エステル
|
JP4405258B2
(ja)
|
2001-06-21 |
2010-01-27 |
ヴェレニウム コーポレイション |
ニトリラーゼ
|
BRPI0212455B8
(pt)
|
2001-09-14 |
2021-05-25 |
Glaxo Group Ltd |
composto derivado de fenetanolamina para o tratamento de doenças respiratórias, formulação farmacêutica, combinação, e, uso do mesmo
|
KR20050030169A
(ko)
|
2001-10-17 |
2005-03-29 |
유씨비 소시에떼아노님 |
퀴누클리딘 유도체, 이의 제조 방법 및 m2 및/또는 m3무스카린 수용체 억제제로서의 이의 용도
|
GB0125259D0
(en)
|
2001-10-20 |
2001-12-12 |
Glaxo Group Ltd |
Novel compounds
|
MY130622A
(en)
|
2001-11-05 |
2007-07-31 |
Novartis Ag |
Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
|
TWI249515B
(en)
|
2001-11-13 |
2006-02-21 |
Theravance Inc |
Aryl aniline beta2 adrenergic receptor agonists
|
WO2003042160A1
(en)
|
2001-11-13 |
2003-05-22 |
Theravance, Inc. |
Aryl aniline beta-2 adrenergic receptor agonists
|
WO2003048181A1
(en)
|
2001-12-01 |
2003-06-12 |
Glaxo Group Limited |
17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
|
BR0215348A
(pt)
|
2001-12-20 |
2004-11-16 |
S A L V A T Lab Sa |
Derivados de carbamato de 1-alquil-1-azoniabiciclo[2-2]octano e uso destes como antagonistas do receptor muscarìnico
|
AU2003202044A1
(en)
|
2002-01-15 |
2003-09-09 |
Glaxo Group Limited |
17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
|
WO2003062259A2
(en)
|
2002-01-21 |
2003-07-31 |
Glaxo Group Limited |
Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
|
GB0202216D0
(en)
|
2002-01-31 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
EP1485093B1
(en)
|
2002-03-12 |
2010-11-03 |
Merck Sharp & Dohme Corp. |
Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
|
US6903215B2
(en)
|
2002-03-26 |
2005-06-07 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
CA2477764A1
(en)
|
2002-03-26 |
2003-10-09 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
AR039209A1
(es)
|
2002-04-03 |
2005-02-09 |
Novartis Ag |
Derivados de indolilmaleimida
|
ATE496620T1
(de)
|
2002-04-11 |
2011-02-15 |
Merck Sharp & Dohme |
1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
|
ES2206021B1
(es)
|
2002-04-16 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de pirrolidinio.
|
DE60318193T2
(de)
|
2002-04-25 |
2008-12-04 |
Glaxo Group Ltd., Greenford |
Phenethanolaminderivate
|
CA2484209C
(en)
|
2002-05-03 |
2013-06-11 |
Exelixis, Inc. |
Protein kinase modulators and methods of use
|
DE10220570A1
(de)
|
2002-05-08 |
2003-11-20 |
Bayer Ag |
Carbamat-substituierte Pyrazolopyridine
|
AU2003239880A1
(en)
|
2002-05-28 |
2003-12-12 |
Theravance, Inc. |
ALKOXY ARYL Beta2 ADRENERGIC RECEPTOR AGONISTS
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
ES2201907B1
(es)
|
2002-05-29 |
2005-06-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
|
DE10224888A1
(de)
|
2002-06-05 |
2003-12-24 |
Merck Patent Gmbh |
Pyridazinderivate
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE10225574A1
(de)
|
2002-06-10 |
2003-12-18 |
Merck Patent Gmbh |
Aryloxime
|
DE10227269A1
(de)
|
2002-06-19 |
2004-01-08 |
Merck Patent Gmbh |
Thiazolderivate
|
JP2006502104A
(ja)
|
2002-06-25 |
2006-01-19 |
メルク フロスト カナダ アンド カンパニー |
8−(ビアリール)キノリンpde4阻害剤
|
ES2204295B1
(es)
|
2002-07-02 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de quinuclidina-amida.
|
JP2005538972A
(ja)
|
2002-07-02 |
2005-12-22 |
メルク フロスト カナダ アンド カンパニー |
ジアリール置換エタンピリドンpde4阻害剤
|
WO2004005229A1
(en)
|
2002-07-08 |
2004-01-15 |
Pfizer Products Inc. |
Modulators of the glucocorticoid receptor
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
PE20050130A1
(es)
|
2002-08-09 |
2005-03-29 |
Novartis Ag |
Compuestos organicos
|
PL373146A1
(pl)
|
2002-08-10 |
2005-08-22 |
Altana Pharma Ag |
Pochodne pirydazynonu jako inhibitory PDE4
|
WO2004017974A1
(en)
|
2002-08-10 |
2004-03-04 |
Altana Pharma Ag |
Piperidine-pyridazones and phthalazones as pde4 inhibitors
|
WO2004018450A1
(en)
|
2002-08-10 |
2004-03-04 |
Altana Pharma Ag |
Piperidine-n-oxide-derivatives
|
AU2003255376A1
(en)
|
2002-08-10 |
2004-03-11 |
Altana Pharma Ag |
Piperidine-derivatives as pde4 inhibitors
|
RS20050117A
(en)
|
2002-08-17 |
2007-06-04 |
Altana Pharma Ag., |
Novel benzonaphthyridines
|
WO2004018431A2
(en)
|
2002-08-17 |
2004-03-04 |
Altana Pharma Ag |
Novel phenanthridines
|
AU2003259747A1
(en)
|
2002-08-21 |
2004-03-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
SE0202483D0
(sv)
|
2002-08-21 |
2002-08-21 |
Astrazeneca Ab |
Chemical compounds
|
EP1534675B1
(en)
|
2002-08-23 |
2009-02-25 |
Ranbaxy Laboratories, Ltd. |
Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo¬3.1.0 hexane derivatives as muscarinic receptor antagonists
|
CN1678306A
(zh)
|
2002-08-29 |
2005-10-05 |
贝林格尔·英格海姆药物公司 |
在炎性、变应性和增生性疾病中用作糖皮质激素模拟物的3-(磺酰氨基乙基)-吲哚衍生物
|
DE60310576T2
(de)
|
2002-08-29 |
2007-10-31 |
Altana Pharma Ag |
2-hydroxy-6-phenylphenanthridine als pde-4-hemmer
|
ATE353217T1
(de)
|
2002-08-29 |
2007-02-15 |
Altana Pharma Ag |
3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
TW200413372A
(en)
|
2002-09-18 |
2004-08-01 |
Ono Pharmaceutical Co |
Derivatives of triazaspiro [5.5] undecane and medicants using such derivatives as effective ingredient
|
JP2006096662A
(ja)
|
2002-09-18 |
2006-04-13 |
Sumitomo Pharmaceut Co Ltd |
新規6−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
JP2004107299A
(ja)
|
2002-09-20 |
2004-04-08 |
Japan Energy Corp |
新規1−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
WO2004026248A2
(en)
|
2002-09-20 |
2004-04-01 |
Merck & Co., Inc. |
Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
|
DE10246374A1
(de)
|
2002-10-04 |
2004-04-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
AU2003269316A1
(en)
|
2002-10-11 |
2004-05-04 |
Pfizer Inc. |
Indole derivatives as beta-2 agonists
|
EP1440966A1
(en)
|
2003-01-10 |
2004-07-28 |
Pfizer Limited |
Indole derivatives useful for the treatment of diseases
|
DE60315492T2
(de)
|
2002-10-22 |
2008-04-24 |
Glaxo Group Ltd., Greenford |
Medizinisch verwendbare arylethanolamin verbindungen
|
KR20050065624A
(ko)
|
2002-10-23 |
2005-06-29 |
그렌마크 파머수티칼스 엘티디. |
염증성 및 알레르기 질환의 치료에 유용한 신규한트리사이클릭 화합물, 이의 제조 방법 및 이를 함유하는약제 조성물
|
US7442839B2
(en)
|
2002-10-28 |
2008-10-28 |
Glaxo Group Limited |
Phenethanolamine derivative for the treatment of respiratory diseases
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225287D0
(en)
|
2002-10-30 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
DE10253282A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
|
DE10253220A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Dihydroxy-Methyl-Phenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
DE10253426B4
(de)
|
2002-11-15 |
2005-09-22 |
Elbion Ag |
Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
|
AU2003297740B2
(en)
|
2002-12-09 |
2008-09-11 |
The Board Of Regents Of The University Of Texas System |
Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)
|
DE10261874A1
(de)
|
2002-12-20 |
2004-07-08 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
US7732432B2
(en)
|
2003-01-21 |
2010-06-08 |
Merck Sharp & Dohme Corp. |
17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
JP2007524596A
(ja)
|
2003-02-28 |
2007-08-30 |
トランスフォーム・ファーマシューティカルズ・インコーポレイテッド |
共結晶医薬組成物
|
EP1460064A1
(en)
|
2003-03-14 |
2004-09-22 |
Pfizer Limited |
Indole-2-carboxamide derivatives useful as beta-2 agonists
|
GB0312832D0
(en)
|
2003-06-04 |
2003-07-09 |
Pfizer Ltd |
2-amino-pyridine derivatives useful for the treatment of diseases
|
AU2004245174A1
(en)
|
2003-06-10 |
2004-12-16 |
Ace Biosciences A/S |
Extracellular Aspergillus polypeptides
|
GB2407042B
(en)
|
2003-10-17 |
2007-10-24 |
Vectura Ltd |
Inhaler
|
CA2545427C
(en)
|
2004-01-12 |
2012-08-21 |
Cytopia Research Pty Ltd |
Selective kinase inhibitors
|
GB0410712D0
(en)
|
2004-05-13 |
2004-06-16 |
Novartis Ag |
Organic compounds
|
WO2006040318A2
(en)
|
2004-10-12 |
2006-04-20 |
Applied Research Systems Ars Holding N.V. |
Pi3 kinase gamma inhibitors for the treatment of anaemia
|
WO2006124874A2
(en)
|
2005-05-12 |
2006-11-23 |
Kalypsys, Inc. |
Inhibitors of b-raf kinase
|
CN101479255B
(zh)
|
2006-03-22 |
2013-05-01 |
沃泰克斯药物股份有限公司 |
用于治疗增殖性病症的c-MET蛋白激酶抑制剂
|
PL2001849T3
(pl)
|
2006-03-29 |
2015-04-30 |
Hoffmann La Roche |
Pochodne pirydyny i pirymidyny jako antagoniści mGluR2
|
JP4960450B2
(ja)
|
2006-07-14 |
2012-06-27 |
ノバルティス アーゲー |
Alk−5阻害剤としてのピリミジン誘導体
|
EP1900727A1
(en)
|
2006-08-30 |
2008-03-19 |
Cellzome Ag |
Aminopyridine derivatives as kinase inhibitors
|
GB0713259D0
(en)
|
2007-07-09 |
2007-08-15 |
Astrazeneca Ab |
Pyrazine derivatives 954
|
ES2394126T3
(es)
*
|
2007-07-26 |
2013-01-22 |
Novartis Ag |
Derivados de pirimidina útiles para el tratamiento de estados inflamatorios o alérgicos
|
KR20100089090A
(ko)
|
2007-10-25 |
2010-08-11 |
아스트라제네카 아베 |
세포 증식 장애의 치료에 유용한 피리딘 및 피라진 유도체
|
US8343966B2
(en)
|
2008-01-11 |
2013-01-01 |
Novartis Ag |
Organic compounds
|
US8268834B2
(en)
*
|
2008-03-19 |
2012-09-18 |
Novartis Ag |
Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
|
SI3354650T1
(sl)
|
2008-12-19 |
2022-06-30 |
Vertex Pharmaceuticals Incorporated |
Spojine, uporabne kot zaviralci ATR kinaze
|
SI2526090T1
(sl)
|
2010-01-18 |
2015-11-30 |
Mmv Medicines For Malaria Venture |
Nova sredstva proti malariji
|
MX2013000537A
(es)
|
2010-07-14 |
2013-01-29 |
Novartis Ag |
Compuestos heterociclicos agonistas del receptor ip.
|
DE102010033690A1
(de)
|
2010-08-06 |
2012-02-09 |
Saltigo Gmbh |
Verfahren zur Herstellung vom Aminoarylalkylverbindungen
|
PT3134396T
(pt)
|
2014-04-24 |
2019-12-16 |
Novartis Ag |
Derivados de amino piridina como inibidores da fosfatidilinositol 3-quinase
|
BR112016024533A8
(pt)
|
2014-04-24 |
2021-03-30 |
Novartis Ag |
derivados de amino pirazina como inibidores de fosfatidilinositol 3-cinase ou sal, seu uso, e composição e combinação farmacêuticas
|